Is opportunistic disease prevention in the consultation ethically justifiable?
about
Recommendations for returning genomic incidental findings? We need to talk!Who needs health care--the well or the sick?Combating disease mongering: daunting but nonetheless essential.Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 populationPriority setting in primary health care - dilemmas and opportunities: a focus group studyPreventive care: so many recommendations, so little time.Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trialOpening the black box: cognitive strategies in family practiceInvestigating the role of the general practitioner in cancer prevention: a mixed methods study.Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.Rethinking scientific responsibility.A population-based nationwide cross-sectional study on preventive health services utilization in Portugal--what services (and frequencies) are deemed necessary by patients?Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.Smoking cessation advice in consultations with health problems not related to smoking? Relevance criteria in Danish general practice consultations.The effect of a test ordering software intervention on the prescription of unnecessary laboratory tests - a randomized controlled trial.Conceptual issues for screening in the genomic era - time for an update?Critiques of the risk concept--valid or not?Individualized population care: linking personal care to population care in general practice.Patients' estimations of the importance of preventive health services: a nationwide, population-based cross-sectional study in Portugal.Screening for suicidal thoughts in primary care: the views of patients and general practitioners.Screening in frail older people: an ounce of prevention or a pound of trouble?Person-centered prevention and health promotion.Brittle bones: ageing or threat of disease exploring women's cultural models of osteoporosis.Awareness of risk of osteoporosis may cause uncertainty and worry in menopausal women.Promotion of disease and corrosion of medicine.Feasibility of opportunistic disease prevention: doctors' responsibilities should not be reduced.Feasibility of opportunistic disease prevention: personal and public health are at stake.Thresholds for normal blood pressure and serum cholesterol.Too much health care and too little care for the sick?Anticipated longevity among lay people screened for cardiovascular risk factors: a cross-sectional questionnaire study.Help-seeking response to subjective memory complaints in older adults: toward a conceptual model.Adherence to preventive statin therapy according to socioeconomic position.Barriers to routine gynecological cancer screening for White and African-American obese women.Risk, statistics, and the individual.Why is quaternary prevention important in prevention?Humour, beauty, and culture as personal health resources: experiences of elderly Swedish women.Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.
P2860
Q26995124-14BD3D66-B33F-4550-9554-7550F65EFC75Q30399217-A3BAED2E-8D31-4235-B9B4-48F996186D10Q33238996-0222136F-118E-4D0B-9F45-0584DEFE0CB7Q33514099-5116C4C5-836B-4015-8308-763EECB75317Q33701010-A8C33D63-DD30-4DCF-9F04-3B1D6761338FQ34132622-BB38A899-0186-4439-ACCE-4E0DDB614B71Q34478966-1C334022-0C9D-4D1E-9D57-0FFCA61B4C41Q34629202-41B7E7A9-A207-4435-8876-BDA23DBEBB58Q34709057-E7D3EB46-0294-405C-9598-D39FD9553DBEQ34901608-01844D79-2A8F-4F04-9D83-63FD6D08502AQ34935873-752A924E-5E49-45A6-A0C2-5DD05C3CEDE6Q35053953-F99C1F20-C85C-4FD9-A018-CF16A781C133Q35148118-522A8834-A85A-4EAE-81E3-31505278EE8EQ35573013-4E94A87B-F4E5-44A0-82BD-230E888AA944Q36241141-6CB595C8-C7F3-49C8-9122-7B91BB77C7ACQ36285753-9DB39C46-B9EA-4723-9EE0-4CDCA4D68F46Q36666844-2E648FF2-A786-474D-9E20-E6795CB5D4AEQ36939706-74B27BCE-EAAC-469C-8D23-2ECD32B51A9DQ37329292-E54D309A-2F56-4F3A-B58E-149678F31A63Q37356159-97A72FBE-183B-4559-94D1-68882DFC0274Q37421497-A0FF250D-CCB9-4FE9-A109-FD3F3835675EQ37798568-0955C1EA-D34D-49B3-BF6E-FE442A1246EFQ39498890-C68BA5E1-21C9-4B53-872B-2BFC45E77171Q40318925-17F601D8-3F8E-4145-8BFC-93A7107B852DQ40402967-C2A1E880-ABC8-4442-A9FD-E05DFC2EE53EQ42407816-0A57A36E-C2F0-4874-B4FE-C1FFC6EF2A78Q43056905-EDDBA0C4-2505-484D-A7E3-758F9F2C8880Q43056907-9583ABAA-1026-49B8-B7BF-0A3BF848B9A8Q43065365-491F9D8F-FC0F-4905-88E8-95C6B6F699B1Q43201122-65C9DD7A-EA58-4621-A072-8DF7FA584A83Q43484054-78BA4899-91BB-4502-9D7C-C2B216FFB00DQ43955808-AA0976C1-31A3-49E4-AFDC-17D229730BC5Q44003644-85BC62C1-7360-498E-9B7B-AA4DFF737613Q45997254-BBFDF4D1-DB03-4D25-A218-CD97C3BCBF07Q46101798-10A9D62F-F884-4B02-96AC-5DB1FA4EB570Q47096461-0EECE253-AAAB-4826-9976-94DA4EA0C9F4Q47783648-20B6D1D9-5B5C-4083-96F5-BEBB83CEC349Q53657751-1AEB3B50-D666-4A10-BF9C-D632909AE9BE
P2860
Is opportunistic disease prevention in the consultation ethically justifiable?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Is opportunistic disease prevention in the consultation ethically justifiable?
@en
Is opportunistic disease prevention in the consultation ethically justifiable?
@nl
type
label
Is opportunistic disease prevention in the consultation ethically justifiable?
@en
Is opportunistic disease prevention in the consultation ethically justifiable?
@nl
prefLabel
Is opportunistic disease prevention in the consultation ethically justifiable?
@en
Is opportunistic disease prevention in the consultation ethically justifiable?
@nl
P2093
P2860
P356
P1433
P1476
Is opportunistic disease prevention in the consultation ethically justifiable?
@en
P2093
Irene Hetlevik
Johann A Sigurdsson
P2860
P304
P356
10.1136/BMJ.327.7413.498
P407
P577
2003-08-01T00:00:00Z